Skip to main content
. Author manuscript; available in PMC: 2024 Jul 8.
Published in final edited form as: Med Phys. 2023 Jun 29;50(8):e865–e903. doi: 10.1002/mp.16536

Table 4.

A summary of clinical studies for pretreatment EPID based PSQA.

System Author Tests performed Results
Dosimetry Check (RadCalc EPID) Chendi et al. 2021 20 FFF plans, compared to Octavius phantom measurement and TPS calculation (in-patient CT) Poor correlation in gamma-pass rates
Epiqa Fogliata et al. 2011 295 patient VMAT plans, 5 centers Mean gamma 97.1±2.4% at 3%,3mm
Epiqa Nicolini et al. 2013 74 arcs VMAT FFF Similar to non FFF if > 150 cm EPID distance
Portal Dosimetry Howell et al. 2008 152 patient IMRT plans (1152 fields) Mean gamma value tolerances established
Portal Dosimetry Iori et al. 2010 23 arcs VMAT Same results as IMRT but using external EPID fixation device
Portal Dosimetry Bailey et al. 2012 Prostate, head neck, breast IMRT (126 fields) Off axis breast tangents lower results, may not adequately model off axis
Portal Dosimetry Ballangrud et al. 2018 40 multitarget SRS deliveries γ pass rate of greater than 95% for most fields at 3%/2 mm criteria with a 10% threshold
Portal Dosimetry Covington et al. 2019 36 plans single-target SRS VMAT QA for at 10FFF energy composite EPID image of the two arcs
3%/2 mm criteria with 10% threshold a 100% pass rate
Portal Dosimetry Koo et al. 2020 200 breast IMRT plans Average gamma passing rate of 98·4 ± 4·3 for 2%/2 mm symmetric plans and 89·7 ± 9·5 for 2%/2 mm asymmetric plans